Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CASPOFUNGIN ACETATE (DKB), with a corresponding US DMF Number 34091.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 09, 2019, and payment made on September 12, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II